Evidence map›Paper›PMID 36714558›Full record

ArticleFrontiers in endocrinology2022

Accuracy of

S Oliviero, E Millard, Z Chen, A Rayson, B C Roberts, H M S Ismail, I Bellantuono, E Dall'Ara

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Exploring theMetabolites · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

S OlivieroInsigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom.
E MillardInsigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Z ChenDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom.
A RaysonDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom.
B C RobertsInsigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom.
H M S IsmailDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
I BellantuonoDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom.
E Dall'AraInsigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom.
University of Sheffield · GBInsigneo · GB

Funding

Medical Research Council MR/P020941/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/R001073/1Versus Arthritis 22048
6 · The paper itself

Abstract

Osteoarthritis (OA) is one of the most common musculoskeletal diseases. OA is characterized by degeneration of the articular cartilage as well as the underlying subchondral bone. Post-traumatic osteoarthritis (PTOA) is a subset of OA caused by mechanical trauma. Mouse models, such as destabilization of the medial meniscus (DMM), are useful to study PTOA.

Indexed as

OsteoarthritisTibiaAnimalsKnee JointMaleMiceMice, Inbred C57BLX-Ray MicrotomographyDMMmicroCTmouse modelsosteoarthritissubchondral bone

Identifiers

PMID36714558
PMCPMC9874301
OpenAlexW4315498423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.